Target intelligence / Profile preview

Palmitoyltransferase ZDHHC14 (ZDHHC14)

Target
ZDHHC14
Molecular classification
Enzyme, Palmitoyl acyltransferase (specifically, DHHC-type palmitoyltransferase), Zinc finger protein
01

Overview

Palmitoyltransferase ZDHHC14 is a member of the DHHC (Asp-His-His-Cys) motif-containing palmitoyl acyltransferases, enzymes responsible for S-palmitoylation of proteins, a post-translational modification involving the addition of palmitate to cysteine residues. ZDHHC14 is distinguished by its unique C-terminal Type-I PDZ ligand (LSSV) and is highly expressed in the hippocampus, where it plays a critical role in palmitoylating and appropriately localizing key neuronal proteins such as PSD93 and Kv1-family potassium channels. Its activity is essential for normal voltage-gated potassium channel clustering at the axon initial segment and thus for regulating neuronal excitability. Loss of ZDHHC14 disrupts this process, affecting electrical properties of neurons. ZDHHC14’s function appears to be non-redundant, and it is intolerant to loss-of-function mutations in humans[1][3][5][4]. There are currently no approved drugs or chemical probes known to selectively target ZDHHC14, and none of its interacting drugs or safety concerns have been identified in clinical settings.

Other names
DHHC-14NEW1CPFLJ20984DHHC domain-containing cysteine-rich protein 14NEW1 domain-containing proteinZinc finger DHHC domain-containing protein 14zinc finger DHHC-type containing 14zinc finger DHHC-type palmitoyltransferase 14zinc finger, DHHC domain containing 14
02

Mechanism of action

Not applicable (no approved drugs or tool compounds known to target ZDHHC14 directly)

03

Biological functions

S-palmitoylation of substrate proteins (attachment of palmitic acid to cysteine residues)Regulation of protein localization and traffickingModulation of neuronal excitability and clustering of ion channels at the axon initial segment (AIS)
04

Disease associations

Neurodevelopmental and neurophysiological regulation (implicated in neuronal excitability)Potential involvement in neurodegenerative conditions or neurological disorders linked to altered neuronal firing (no direct disease causation established)
05

Safety considerations

No clinical inhibitors or modulators reported; loss-of-function intolerance in humans suggests essential physiological roles and possible toxicity if interfered with systemically
06

Biomarkers

None established; changes in PSD93/Kv1 palmitoylation or localization could be research biomarkers in neuronal studies

Beyond the preview

Go deeper on Palmitoyltransferase ZDHHC14 (ZDHHC14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Palmitoyltransferase ZDHHC14 (ZDHHC14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call